Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age
      Description

      The purpose of this study was to show that quadrivalent live attenuated influenza vaccine (Q/LAIV-BFS; MEDI8662) was at least as immunogenic as two different forms of the commercial vaccine, FluMist, by comparing the strain-specific antibody levels in the blood.

      Conditions
      Healthy or Stable Underlying Chronic Medical Condition
      Talk to us
      COMPLETED
      A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age
      Description

      The objective of this study was to show that quadrivalent live attenuated influenza vaccine (Q/LAIV; MEDI3250) produced antibody levels similar to those produced by the commercial vaccine, FluMist.

      Conditions
      Healthy or Stable Underlying Chronic Medical Condition
      Talk to us